Effect of Naltrexone-Bupropion on Major Adverse Cardiovascular Events in Overweight and Obese Patients With Cardiovascular Risk Factors: A Randomized Clinical Trial
Author(s) -
Steven E. Nissen,
Kathy Wolski,
Lisa Prcela,
Thomas A. Wadden,
John B. Buse,
George L. Bakris,
Alfonso García Pérez,
Steven R. Smith
Publication year - 2016
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/32qq-vc12
Subject(s) - bupropion , medicine , naltrexone , overweight , randomized controlled trial , adverse effect , obesity , smoking cessation , opioid , receptor , pathology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom